Navigation Links
Another Batch of Birth Control Pills Recalled for Faulty Packaging
Date:2/27/2012

MONDAY, Feb. 27 (HealthDay News) -- A second company has issued a voluntary recall of birth control pills because of a packaging error that could lead to incorrect dosing and expose women to unintended pregnancies.

Glenmark Generics Inc. said the seven lots of birth control pill packets, sold as Norgestimate and Ethinyl Estradiol, do not pose any immediate health risks, but that women using these oral contraceptives should immediately switch to another form of birth control. The company added that it has informed the U.S. Food and Drug Administration of the recall.

"The safety of patients who take our medicines is our first priority. The cause was identified and corrected immediately," the company said in a statement. "At this time, there remains sufficient supply of unaffected lots of material in the marketplace to support demand."

Glenmark did not specify how many pills were affected by the recall. The lot numbers on the packets are: 04110101, 04110106, 04110107, 04110114, 04110124, 04110129 and 04110134.

Doctors offered this advice to women who may be affected by the recall.

"With birth control pills, if the exact count or sequence is out of order the efficacy of the birth control pill could be significantly decreased. If this is the case, patients may be experiencing irregular bleeding and may be at higher risk for unintended pregnancy," said Dr. Adam Jacobs, an assistant professor of obstetrics, gynecology and reproductive science at Mount Sinai Medical Center in New York City.

"This packaging error does not pose any other immediate health risks. If a patient has this lot number they should stop taking the pills immediately and discuss other birth control options with their physician, including emergency contraception, if necessary," Jacobs added.

"Sequence and content of active vs. inactive pills is crucial in determining efficacy, including whether or not unwanted pregnancy will be actually prevented," said Dr. Jill Rabin, chief of ambulatory care, obstetrics and gynecology at Long Island Jewish Medical Center in New Hyde Park, N.Y. "Expiration date could also affect efficacy of the pill in question, as active ingredient potency may be affected. Fortunately, the exact cause of this packaging error was identified and immediately reported."

However, patients who are affected by this should do several important things, Rabin added. Make sure you are not pregnant; immediately begin using a non-hormonal form of contraception if not pregnant; notify your physician/health care provider; and return the product to your pharmacy.

The pills involved in the latest recall were sent to wholesalers and retail pharmacies nationwide between Sept. 21, 2011 and Dec. 30, 2011. Glenmark said it discovered the packaging problem after a customer complained that one of her blister packs had the pills packaged in reverse order.

Earlier this month, Pfizer Inc. recalled 1 million packets of birth control pills for similar reasons. At the time, the company said it had discovered that some blister packs of Lo/Ovral and generic Norgestrel and Ethinyl Estradiol had packaging that could contain either too many or too few active pills and that the pills may be out of sequence. The expiration dates on those recalled packets range between July 31, 2013 and March 31, 2014.

More information

Here's where you can find more details on the Glenmark recall.

-- HealthDay staff

SOURCES: Adam Jacobs, M.D., assistant professor, obstetrics, gynecology and reproductive science, Mount Sinai Medical Center, New York City; Jill Rabin, M.D., chief, ambulatory care, obstetrics and gynecology, head, urogynecology, Long Island Jewish Medical Center, New Hyde Park, N.Y.; U.S. Food and Drug Administration, news release, Feb. 27, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Another clue in the mystery of autism
2. Study finds another potential risk factor for developing dementia and Alzheimers disease in women
3. Heads up Kobe Bryant! Research shows that trying for another 3-pointer is a mistake
4. Fungi: Another tool in bacterias belt?
5. Another clue to how obesity works
6. As One Life Starts, Another May Be Saved
7. No One Treatment for Acid Reflux Clearly Better Than Another: Study
8. Another Blood Test for Alzheimers Shows Promise
9. FDA Approves Another New Drug to Fight Hepatitis C
10. Study suggests another look at testosterone-prostate cancer link
11. FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Another Batch of  Birth Control Pills Recalled for Faulty Packaging
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of ... can get while staying in compliance with FDA rules. , The FDA has ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, IL on ... industry for ensuring label quality and improving patient safety. , Microscan ...
(Date:9/21/2017)... , ... September 21, 2017 , ... FlipBelt, the fitness ... attention to detail to the athletic wear market with the launch of their FlipBelt ... can have their essentials securely at their fingertips while at the gym, on the ...
(Date:9/20/2017)... ... 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), combines strategies ... Intelligence (AI) thinking, announced today the launch of its revamped web presence. ... that offers a more comprehensive understanding of the organization’s business and machine learning ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... WASHINGTON , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, ... to Washington, D.C. offering free MRI brain scans to the public.Where:  ... – will be parked at 501 K Street NW, Washington, D.C.What:BTF brings ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
Breaking Medicine Technology: